Pharmaceuticals in France

Date: June 30, 2017
Pages: 34
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PFACDE709F7EN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in France
Pharmaceuticals in France

SUMMARY

Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

SYNOPSIS

Essential resource for top-line data and analysis covering the France pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

KEY HIGHLIGHTS
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.
  • The French pharmaceuticals market had total revenues of $35.6bn in 2016, representing a compound annual rate of change (CARC) of -1% between 2012 and 2016.
  • The French market’s previous declines are largely due to the trend in developed markets to cut costs and spending on highly expensive branded drugs and find alternatives.
  • The pharmaceutical market of France holds leadership position in the production of vaccines; however, it shows a disappointing performance in the manufacturing of biological products.
SCOPE
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in France
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in France
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the France pharmaceuticals market with five year forecasts
REASONS TO BUY
  • What was the size of the France pharmaceuticals market by value in 2016?
  • What will be the size of the France pharmaceuticals market in 2021?
  • What factors are affecting the strength of competition in the France pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in France's pharmaceuticals market?
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
AstraZeneca PLC
Laboratoires Pierre Fabre SA
Sanofi SA
Les Laboratoires Servier
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: France pharmaceuticals market value: $ billion, 2012–16
Table 2: France pharmaceuticals market geography segmentation: $ billion, 2016
Table 3: France pharmaceuticals market share: % share, by value, 2016
Table 4: France pharmaceuticals market value forecast: $ billion, 2016–21
Table 5: AstraZeneca PLC: key facts
Table 6: AstraZeneca PLC: key financials ($)
Table 7: AstraZeneca PLC: key financial ratios
Table 8: Laboratoires Pierre Fabre SA: key facts
Table 9: Sanofi SA: key facts
Table 10: Sanofi SA: key financials ($)
Table 11: Sanofi SA: key financials (€)
Table 12: Sanofi SA: key financial ratios
Table 13: Les Laboratoires Servier: key facts
Table 14: France size of population (million), 2012–16
Table 15: France gdp (constant 2005 prices, $ billion), 2012–16
Table 16: France gdp (current prices, $ billion), 2012–16
Table 17: France inflation, 2012–16
Table 18: France consumer price index (absolute), 2012–16
Table 19: France exchange rate, 2012–16

LIST OF FIGURES

Figure 1: France pharmaceuticals market value: $ billion, 2012–16
Figure 2: France pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 3: France pharmaceuticals market share: % share, by value, 2016
Figure 4: France pharmaceuticals market value forecast: $ billion, 2016–21
Figure 5: Forces driving competition in the pharmaceuticals market in France, 2016
Figure 6: Drivers of buyer power in the pharmaceuticals market in France, 2016
Figure 7: Drivers of supplier power in the pharmaceuticals market in France, 2016
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2016
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2016
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in France, 2016
Figure 11: AstraZeneca PLC: revenues & profitability
Figure 12: AstraZeneca PLC: assets & liabilities
Figure 13: Sanofi SA: revenues & profitability
Figure 14: Sanofi SA: assets & liabilities

COMPANIES MENTIONED

AstraZeneca PLC
Laboratoires Pierre Fabre SA
Sanofi SA
Les Laboratoires Servier
Skip to top


OTC Pharmaceuticals in France US$ 350.00 Sep, 2016 · 37 pages
Pharmaceuticals Global Industry Guide 2017 US$ 1,495.00 May, 2017 · 298 pages

Ask Your Question

Pharmaceuticals in France
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: